Dan Paterson Founder of Verastem Oncology Backed byBiotechnology Value FundGorjan Hrustanovic LinkedIn SourcesVerastem's CEO Dan Paterson discusses the launch of the Avmapki Fakzynja Co-Pack for KRAS-mutated recurrent low-grade serous ovarian cancer, and other pipeline projects — 2025-04 Browse all founders · Browse investors
